229 related articles for article (PubMed ID: 15148250)
1. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
[TBL] [Abstract][Full Text] [Related]
2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
3. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA).
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2004 Mar; 141(5):803-12. PubMed ID: 14769783
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries.
Wheal AJ; Alexander SP; Randall MD
Eur J Pharmacol; 2012 Jan; 674(2-3):384-90. PubMed ID: 22154756
[TBL] [Abstract][Full Text] [Related]
7. Effects of hypertension on vasorelaxation to endocannabinoids in vitro.
Wheal AJ; Randall MD
Eur J Pharmacol; 2009 Jan; 603(1-3):79-85. PubMed ID: 19100733
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed.
Harris D; McCulloch AI; Kendall DA; Randall MD
J Physiol; 2002 Mar; 539(Pt 3):893-902. PubMed ID: 11897858
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
10. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
Poblete IM; Orliac ML; Briones R; Adler-Graschinsky E; Huidobro-Toro JP
J Physiol; 2005 Oct; 568(Pt 2):539-51. PubMed ID: 16081483
[TBL] [Abstract][Full Text] [Related]
11. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
Hoi PM; Hiley CR
Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
[TBL] [Abstract][Full Text] [Related]
12. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
13. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
Ho WS; Hiley CR
J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
[TBL] [Abstract][Full Text] [Related]
14. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
Mendizábal VE; Orliac ML; Adler-Graschinsky E
Eur J Pharmacol; 2001 Sep; 427(3):251-62. PubMed ID: 11567656
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Pharmacol Res; 2016 Nov; 113(Pt A):356-363. PubMed ID: 27633407
[TBL] [Abstract][Full Text] [Related]
16. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W
Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery.
AlSuleimani YM; Hiley CR
Eur J Pharmacol; 2013 Feb; 702(1-3):1-11. PubMed ID: 23340219
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
19. Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery.
Zygmunt PM; Sørgård M; Petersson J; Johansson R; Högestätt ED
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):535-42. PubMed ID: 10832608
[TBL] [Abstract][Full Text] [Related]
20. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
Plane F; Holland M; Waldron GJ; Garland CJ; Boyle JP
Br J Pharmacol; 1997 Aug; 121(8):1509-11. PubMed ID: 9283682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
